Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $90.08 million. The enterprise value is $31.91 million.

Market Cap	90.08M
Enterprise Value	31.91M

Important Dates

The next estimated earnings date is Thursday, February 20, 2025, before market open.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Immunic has 90.08 million shares outstanding. The number of shares has increased by 101.53% in one year.

Current Share Class	90.08M
Shares Outstanding	90.08M
Shares Change (YoY)	+101.53%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.25%
Owned by Institutions (%)	26.11%
Float	51.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.19
P/TBV Ratio	2.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.02.

Current Ratio	2.71
Quick Ratio	2.56
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -216.24% and return on invested capital (ROIC) is -130.20%.

Return on Equity (ROE)	-216.24%
Return on Assets (ROA)	-90.90%
Return on Capital (ROIC)	-130.20%
Revenue Per Employee	n/a
Profits Per Employee	-$1.26M
Employee Count	77
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.93% in the last 52 weeks. The beta is 1.86, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.86
52-Week Price Change	-25.93%
50-Day Moving Average	1.24
200-Day Moving Average	1.32
Relative Strength Index (RSI)	34.81
Average Volume (20 Days)	853,742

Short Selling Information

The latest short interest is 4.19 million, so 4.66% of the outstanding shares have been sold short.

Short Interest	4.19M
Short Previous Month	3.80M
Short % of Shares Out	4.66%
Short % of Float	8.07%
Short Ratio (days to cover)	4.69

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-95.80M
Pretax Income	-95.31M
Net Income	-96.90M
EBITDA	-95.68M
EBIT	-95.80M
Earnings Per Share (EPS)	-$1.12

Full Income Statement

Balance Sheet

The company has $59.07 million in cash and $899,000 in debt, giving a net cash position of $58.17 million or $0.65 per share.

Cash & Cash Equivalents	59.07M
Total Debt	899,000
Net Cash	58.17M
Net Cash Per Share	$0.65
Equity (Book Value)	41.22M
Book Value Per Share	0.46
Working Capital	39.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.83 million and capital expenditures -$426,000, giving a free cash flow of -$76.26 million.

Operating Cash Flow	-75.83M
Capital Expenditures	-426,000
Free Cash Flow	-76.26M
FCF Per Share	-$0.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-101.53%
Shareholder Yield	-101.53%
Earnings Yield	-107.58%
FCF Yield	-84.65%

Analyst Forecast

The average price target for Immunic is $12.67, which is 1,167.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.67
Price Target Difference	1,167.00%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1